William R. Carapezzi Jr.

William R. Carapezzi Jr. (chief executive) discloses dealings in 3 companies, chiefly Pfizer Inc, Lucent Technologies Inc and Duff & Phelps Corp. Between 20 February 2006 and 12 May 2022, the trades on record add up to 30 filings.

The open-market side counts 1 purchase for €31k alongside 2 sales for €1.8M. Sales outweigh purchases by €1.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 21 share grants and 4 option exercises. In 2022 alone, the filings show no purchases and 1 sale.

The record was last updated on 13 May 2022 with an open-market sale (€1.6M) in Pfizer Inc. The most recent open-market purchase was published on 29 August 2008, 6,630 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.